- SOLIFENACIN USP/EP/BP
-
- $1.10
-
2026-08-20
- CAS:180272-14-4
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
- SOLIFENACIN
-
-
2026-08-08
- CAS:180272-14-4
- Min. Order: 1g
- Purity: 99% HPLC
- Supply Ability: 100kg
- SOLIFENACIN
-
-
2026-06-30
- CAS:180272-14-4
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1000kg
|
| | SOLIFENACIN Basic information |
| Product Name: | SOLIFENACIN | | Synonyms: | 1(S)-Phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 3(R)-quinuclidinyl ester;Solifenacin;quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate;(R)-quinuclidin-3-yl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate;2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester;1-AZABICYCLO[2.2.2]OCTAN-3-YL 1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLATE;SOLIFENACIN USP/EP/BP;Solifenacin Succinate (mixture of diastereomers) | | CAS: | 180272-14-4 | | MF: | C23H26N2O2 | | MW: | 362.47 | | EINECS: | | | Product Categories: | | | Mol File: | 180272-14-4.mol |  |
| | SOLIFENACIN Chemical Properties |
| Boiling point | 505.5±50.0 °C(Predicted) | | density | 1.24±0.1 g/cm3(Predicted) | | pka | 9.03±0.33(Predicted) | | BCS Class | 3 |
| | SOLIFENACIN Usage And Synthesis |
| Uses | Racemic Solifenacin Succinate is a muscarinic M3 receptor antagoinst used in treatment of urinary incontinence. |
| | SOLIFENACIN Preparation Products And Raw materials |
|